Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Completion of investment by Life Biosciences LLC and capital raising update

April 8, 2019 Kerry Rowe

Completion of investment by Life Biosciences LLC and capital raising update

Post navigation

Results of General Meeting

Change of Company Name

Related Posts

PBT434 drug candidate shows potential as “next-generation” disease-modifying treatment in Parkinson’s Disease

July 17, 2013

Prana receives $6.8 million R&D Tax Incentive Refund

June 19, 2015

Quarterly Cash Flow Report

August 1, 2019May 19, 2021

Recent Posts

Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
Presentation of New Biomarker Data at Scientific Congress
XBRL 30 June 2021 filed with the SEC
Alterity Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer’s and Parkinson’s
Quarterly Cash Flow Report

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065